CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) - USD ($)	Total	Separation-related adjustment	Adjusted Balance	Common Stock	Common Stock Adjusted Balance	Additional paid-in capital	Additional paid-in capital Separation-related adjustment	Additional paid-in capital Adjusted Balance	Accumulated deficit	Accumulated deficit Adjusted Balance	Accumulated other comprehensive income/(loss)	Accumulated other comprehensive income/(loss) Separation-related adjustment	Accumulated other comprehensive income/(loss) Adjusted Balance
Equity at beginning of the period (in shares) at Dec. 31, 2021				220,000,000	220,000,000
Equity at beginning of the period at Dec. 31, 2021	$ 10,699,389	$ (675,620)	$ 10,023,769	$ 220,000	$ 220,000	$ 53,489,579	$ (707,846)	$ 52,781,733	$ (42,977,964)	$ (42,977,964)	$ (32,226)	$ 32,226	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(10,010,008)								(10,010,008)
Contributions from Parent	732,776					732,776
Equity at end of the period (in shares) at Mar. 31, 2022				220,000,000
Equity at end of the period at Mar. 31, 2022	746,537			$ 220,000		53,514,509			(52,987,972)		0
Equity at beginning of the period (in shares) at Dec. 31, 2021				220,000,000	220,000,000
Equity at beginning of the period at Dec. 31, 2021	10,699,389	$ (675,620)	$ 10,023,769	$ 220,000	$ 220,000	53,489,579	$ (707,846)	$ 52,781,733	(42,977,964)	$ (42,977,964)	(32,226)	$ 32,226	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(153,976,295)
Equity at end of the period (in shares) at Sep. 30, 2022				266,371,485
Equity at end of the period at Sep. 30, 2022	304,675,566			$ 266,371		501,363,454			(196,954,259)		0
Equity at beginning of the period (in shares) at Mar. 31, 2022				220,000,000
Equity at beginning of the period at Mar. 31, 2022	746,537			$ 220,000		53,514,509			(52,987,972)		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(107,221,565)								(107,221,565)
Contributions from Parent	(2,105,409)					(2,105,409)
Share-based compensation and issuance of stock (in shares)				140,000
Share-based compensation and issuance of stock	1,935,988			$ 140		1,935,848
Share based payment with non-employees	1,028,182					1,028,182
Reclassification of Public Warrants from liability to equity	10,580,000					10,580,000
Issuance of fully vested New Warrants	87,352,000					87,352,000
Issuance of common stock upon reverse recapitalization, net of fees (in shares)				43,392,132
Issuance of common stock upon reverse recapitalization, net of fees	315,326,717			$ 43,392		315,283,325
Exercise of public warrants (in shares)				800,000
Exercise of public warrants	8,000			$ 800		7,200
Equity at end of the period (in shares) at Jun. 30, 2022				264,332,132
Equity at end of the period at Jun. 30, 2022	307,650,450			$ 264,332		467,595,655			(160,209,537)		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(36,744,722)								(36,744,722)
Issuance of New Shares (in shares)				2,039,353
Issuance of New Shares	15,000,000			$ 2,039		14,997,961
Issuance of fully vested New Warrants	17,424,230					17,424,230
Share based payment with non-employees	691,909					691,909
Issuance of restricted stock and restricted stock expense	653,699					653,699
Equity at end of the period (in shares) at Sep. 30, 2022				266,371,485
Equity at end of the period at Sep. 30, 2022	304,675,566			$ 266,371		501,363,454			(196,954,259)		$ 0
Equity at beginning of the period (in shares) at Dec. 31, 2022				269,094,021
Equity at beginning of the period at Dec. 31, 2022	286,922,343			$ 269,094		503,661,571			(217,008,322)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(25,771,982)								(25,771,982)
Share-based compensation	867,893					867,893
Share based payment with non-employees	480,000					480,000
Equity at end of the period (in shares) at Mar. 31, 2023				269,094,021
Equity at end of the period at Mar. 31, 2023	262,498,254			$ 269,094		505,009,464			(242,780,304)
Equity at beginning of the period (in shares) at Dec. 31, 2022				269,094,021
Equity at beginning of the period at Dec. 31, 2022	286,922,343			$ 269,094		503,661,571			(217,008,322)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(88,391,854)
Equity at end of the period (in shares) at Sep. 30, 2023				269,209,021
Equity at end of the period at Sep. 30, 2023	202,044,815			$ 269,209		507,175,781			(305,400,175)
Equity at beginning of the period (in shares) at Mar. 31, 2023				269,094,021
Equity at beginning of the period at Mar. 31, 2023	262,498,254			$ 269,094		505,009,464			(242,780,304)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(31,410,026)								(31,410,026)
Share-based compensation and issuance of stock (in shares)				69,900
Share-based compensation and issuance of stock	650,075			$ 70		650,005
Equity at end of the period (in shares) at Jun. 30, 2023				269,163,921
Equity at end of the period at Jun. 30, 2023	231,738,303			$ 269,164		505,659,469			(274,190,330)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(31,209,845)								(31,209,845)
Share-based compensation and issuance of stock (in shares)				45,000
Share-based compensation and issuance of stock	1,515,207			$ 45		1,515,162
Exercise of public warrants (in shares)				100
Exercise of public warrants	1,150					1,150
Equity at end of the period (in shares) at Sep. 30, 2023				269,209,021
Equity at end of the period at Sep. 30, 2023	$ 202,044,815			$ 269,209		$ 507,175,781			$ (305,400,175)